The fourth Fragment-Based Drug Discovery Down Under Meeting (FBDD-DU3) will be held at the Monash Institute of Pharmaceutical Sciences, in Melbourne from 28 to 30 September 2022.
The 2022 conference will bring together an expanding multidisciplinary group of biologists, biochemists, biophysicists, and chemists from academia and industry to hear about the latest techniques and progress in the dynamic and exciting field of fragment-based drug design.
Abstract submission deadlines
Oral presentation abstracts – 15 July 2022
Poster abstracts – 12 August 2022
Registration is now open
Registration closes – 14 September 2022 (5 pm AEST)
- Martin Scanlon (Chair)
- Olga Ilyichova
- Bradley Doak
- Indu Chandrashekaran
- Menachem Gunzburg
- Luke Adams
- Anne Meyer
Please contact email@example.com if you have any questions